[1] |
G. Van den Mooter: "The use of amorphous solid dispersions: A formulation strategy to overcome poor solubility and dissolution rate" Drug Discov. Today Technol., vol. 9, pp. e79–e85, Jun. 2012. |
[2] |
D. E. Alonzo, G. G. Z. Zhang, D. Zhou, Y. Gao, and L. S. Taylor: "Understanding the Behavior of Amorphous Pharmaceutical Systems during Dissolution" Pharm. Res., vol. 27, pp. 608–618, Apr. 2010. |
[3] |
A. Prudic, Y. Ji, C. Luebbert, and G. Sadowski: "Influence of humidity on the phase behavior of API/polymer formulations" Eur. J. Pharm. Biopharm., vol. 94, pp. 352–362, Aug. 2015. |
[4] |
C. Luebbert, F. Huxoll, and G. Sadowski: "Amorphous-Amorphous Phase Separation in API/Polymer Formulations" Molecules, vol. 22, pp. 1–17, Feb. 2017. |